Investigating the Influence of Morphine and Cocaine on the Mesolimbic Pathway Using a Novel Microimaging Platform
-
Published:2023-11-14
Issue:22
Volume:24
Page:16303
-
ISSN:1422-0067
-
Container-title:International Journal of Molecular Sciences
-
language:en
-
Short-container-title:IJMS
Author:
Ganaway Austin1ORCID, Tatsuta Kousuke2, Castillo Virgil Christian Garcia3, Okada Ryoma3ORCID, Sunaga Yoshinori3, Ohta Yasumi3ORCID, Ohta Jun3ORCID, Ohsawa Masahiro2, Akay Metin1ORCID, Akay Yasemin M.1ORCID
Affiliation:
1. Biomedical Engineering Department, University of Houston, 3517 Cullen Blvd, Houston, TX 77204, USA 2. Department of Neuropharmacology, Faculty of Pharmaceutical Sciences, Nagoya City University, Nagoya 467-8601, Japan 3. Division of Materials Science, Graduate School of Science and Technology, Nara Institute of Science and Technology, Ikoma 630-0101, Japan
Abstract
Dopamine (DA)’s relationship with addiction is complex, and the related pathways in the mesocorticolimbic system are used to deliver DA, regulating both behavioral and perceptual actions. Specifically, the mesolimbic pathway connecting the ventral tegmental area (VTA) and the nucleus accumbens (NAc) is crucial in regulating memory, emotion, motivation, and behavior due to its responsibility to modulate dopamine. To better investigate the relationship between DA and addiction, more advanced mapping methods are necessary to monitor its production and propagation accurately and efficiently. In this study, we incorporate dLight1.2 adeno-associated virus (AAV) into our latest CMOS (complementary metal-oxide semiconductor) imaging platform to investigate the effects of two pharmacological substances, morphine and cocaine, in the NAc using adult mice. By implanting our self-fabricated CMOS imaging device into the deep brain, fluorescence imaging of the NAc using the dLight1.2 AAV allows for the visualization of DA molecules delivered from the VTA in real time. Our results suggest that changes in extracellular DA can be observed with this adapted system, showing potential for new applications and methods for approaching addiction studies. Additionally, we can identify the unique characteristic trend of DA release for both morphine and cocaine, further validating the underlying biochemical mechanisms used to modulate dopaminergic activation.
Funder
JSPS Fostering Joint International Research Ministry of Education, Science, Sports University of Houston
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference38 articles.
1. Role of dopamine in drug reinforcement and addiction in humans: Results from imaging studies;Volkow;Behav. Pharmacol.,2002 2. Reward system and addiction: What dopamine does and doesn’t do;Dichiara;Curr. Opin. Pharmacol.,2007 3. Volkow, N.D., Fowler, J.S., Wang, G.-J., and Swanson, J.M. (2023, June 25). Dopamine in Drug Abuse and Addiction Results of Imaging Studies and Treatment Implications. Available online: https://jamanetwork.com/. 4. The comorbidity of insomnia, chronic pain, and depression: Dopamine as a putative mechanism;Finan;Sleep Med. Rev.,2013 5. Phasic Excitation of Dopamine Neurons in Ventral VTA by Noxious Stimuli;Brischoux;Proc. Natl. Acad. Sci. USA,2009
|
|